Skip to main content

Table 2 The immunization and challenge methods in the treatment groups in the survival rate experiment

From: Recombinant tandem epitope vaccination provides cross protection against Actinobacillus pleuropneumoniae challenge in mice

Group

Group name

Number of animals

immunization

Dose of immunization

Challenge

1

PBSC1

10

PBS

0.2 mL/per mouse

APP1

2

PBSC5

10

PBS

0.2 mL/per mouse

APP5b

3

RTAC1

10

RTA

100 μg/0.2 mL/per mouse

APP1

4

IB1-C1

10

inactivated APP1

108 CFU of APP1/0.2 mL/per mouse

APP1

5

IB1-C5

10

inactivated APP1

108 CFU of APP1/0.2 mL/per mouse

APP5b

6

IB5-C1

10

inactivated APP5b

108 CFU of APP5b/0.2 mL/per mouse

APP1

7

IB5-C5

10

inactivated APP5b

108 CFU of APP5b/0.2 mL/per mouse

APP5b

8

RTAIB1 + C1

6

RTA +inactivated APP1

100 μg of RTA + 108 CFU of APP1/0.2 mL/per mouse

APP1

9

RTAIB1 + C5

6

RTA +inactivated APP1

100 μg of RTA + 108 CFU of APP1/0.2 mL/per mouse

APP5b

10

RTAIB5 + C1

6

RTA +inactivated APP5b

100 μg of RTA + 108 CFU of APP5b/0.2 mL/per mouse

APP1

11

RTAIB5 + C5

6

RTA +inactivated APP5b

100 μg of RTA + 108 CFU of APP5b/0.2 mL/per mouse

APP5b

  1. Scheme parameters: Observation of the survival rate